Cytokine stimulation of parasitic and microbial growth.
Denis
M
M
Bioscience 1, ICI Pharmaceuticals, Macclesfield, Cheshire, UK.
Campbell
D
D
Gregg
E O
EO
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D004926:Escherichia coli / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity; D005827:Genetics, Microbial; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000494:pharmacology*; D015850:Interleukin-6 / Q000494:pharmacology*; D008264:Macrophages / Q000382:microbiology; D009164:Mycobacterium Infections / Q000139:chemically induced / Q000150:complications / Q000235:genetics / Q000382:microbiology; D009162:Mycobacterium avium / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity; D009894:Opportunistic Infections / Q000139:chemically induced / Q000150:complications / Q000235:genetics / Q000382:microbiology; D013268:Stimulation, Chemical; D014774:Virulence
D007376:Interleukin-2; D015850:Interleukin-6; D016178:Granulocyte-Macrophage Colony-Stimulating Factor